MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10067-025-07695-3

Медицинская библиотека · Clinical rheumatology · 2025

Anti-CD74 IgA as a potential biomarker in axial spondyloarthritis: diagnostic utility and clinical implications.

Ammar Gehad Elsayed Mohammed, Eldeeb Ali Eed, Mourad Heba Ahmed, Tabra Samar AbdAlhamed

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Axial spondyloarthritis (axSpA) is chronic autoimmune disease affecting axial skeleton. Recently autoantibodies against CD74 have been linked to the pathogenesis of axSpA.

OBJECTIVES

Investigate the diagnostic value of anti-CD74 in Egyptian axSpA patients and their relation to disease activity.

METHODS

This study included 30 axSpA patients and control groups, which included 30 patients with peripheral psoriatic arthritis, and 30 healthy volunteers. disease activity was assessed using ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score) and BASDAI (bath ankylosing spondylitis disease activity index) for axSpA patients. Bath ankylosing spondylitis functional index (BASFI) was used for functional assessment and mobility was assessed using Bath Ankylosing Spondylitis Metrology Index (BASMI). ESR, CRP and serum anti-CD74 IgA were evaluated.

RESULTS

There was no significant difference between the three studied groups regarding sex, age, and BMI. The serum levels of anti-CD74 IgA antibodies were significantly higher in axSpA patients compared to control groups.73.3, 66.6 and 3.3% of the axSpA, Peripheral psoriatic arthritis and healthy group, respectively, were anti- CD74 IgA antibody positive. Its specificity was 96.67% compared to the healthy control group, and 33.3% specificity compared to the peripheral psoriatic arthritis group. There was no significant correlation between anti-CD74 IgA antibodies and age, sex, duration of the disease, acute phase reactant, ASDAS-CRP, BASDAI, BASFI, and BASMI.

CONCLUSIONS

IgA anti-CD74 may be a useful marker for identifying axSpA. Further research on patients with peripheral SpA is required to determine the practical benefits of this biomarker.

Для цитирования: Ammar Gehad Elsayed Mohammed, Eldeeb Ali Eed, Mourad Heba Ahmed, Tabra Samar AbdAlhamed. Anti-CD74 IgA as a potential biomarker in axial spondyloarthritis: diagnostic utility and clinical implications.. Clinical rheumatology. 2025. DOI: 10.1007/s10067-025-07695-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.